Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective and noncovalent targeting of RAS mutants for inhibition and degradation
Kai Wen Teng, Steven T. Tsai, Takamitsu Hattori, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

KRAS mutation: from undruggable to druggable in cancer
Lamei Huang, Zhixing Guo, Fang Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 593
PROTACs: past, present and future
Ke Li, Craig M. Crews
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5214-5236
Open Access | Times Cited: 417
Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
Ziyang Zhang, Keelan Z. Guiley, Kevan M. Shokat
Nature Chemical Biology (2022) Vol. 18, Iss. 11, pp. 1177-1183
Open Access | Times Cited: 102
KRAS is vulnerable to reversible switch-II pocket engagement in cells
James D. Vasta, D. Matthew Peacock, Qinheng Zheng, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 6, pp. 596-604
Open Access | Times Cited: 77
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 65
Dynamic regulation of RAS and RAS signaling
Walter Kölch, Dénes Berta, Edina Rosta
Biochemical Journal (2023) Vol. 480, Iss. 1, pp. 1-23
Open Access | Times Cited: 53
Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
Takamitsu Hattori, Lorenzo Maso, Kiyomi Y. Araki, et al.
Cancer Discovery (2022) Vol. 13, Iss. 1, pp. 132-145
Open Access | Times Cited: 52
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS
Guowei Yin, Jing Huang, Johnny Petela, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Opportunities and challenges of protein-based targeted protein degradation
Fangfang Shen, Laura M. K. Dassama
Chemical Science (2023) Vol. 14, Iss. 32, pp. 8433-8447
Open Access | Times Cited: 22
Post-translational modification of RAS proteins
Sharon L. Campbell, Mark R. Philips
Current Opinion in Structural Biology (2021) Vol. 71, pp. 180-192
Open Access | Times Cited: 50
Eliminating oncogenic RAS: back to the future at the drawing board
Candy Laura Steffen, Pelin Kaya, Elisabeth Schaffner‐Reckinger, et al.
Biochemical Society Transactions (2023) Vol. 51, Iss. 1, pp. 447-456
Open Access | Times Cited: 19
RAS degraders: The new frontier for RAS-driven cancers
Taylor E. Escher, K.J.F. Satchell
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 1904-1919
Open Access | Times Cited: 19
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes
Jonathan D. Taylor, Nathalie Barrett, Sergio Martínez Cuesta, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Targeting KRAS mutant lung cancer: light at the end of the tunnel
Matthias Drosten, Mariano Barbacid
Molecular Oncology (2021) Vol. 16, Iss. 5, pp. 1057-1071
Open Access | Times Cited: 38
Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors
Padma Akkapeddi, Takamitsu Hattori, Imran Mahmood Khan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 28
Open Access | Times Cited: 15
Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases
Harufumi Maki, Reed I. Ayabe, Antony Haddad, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2425-2434
Closed Access
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Advancements in gene therapies targeting mutant KRAS in cancers
Yuhang Wang, Thuỳ Anh Bùi, Xinpu Yang, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation
Susanna Cogo, Franz Y. Ho, Elena Tosoni, et al.
Brain Research (2022) Vol. 1778, pp. 147781-147781
Open Access | Times Cited: 21
Delineating the RAS Conformational Landscape
Mitchell I. Parker, Joshua E. Meyer, Erica A. Golemis, et al.
Cancer Research (2022) Vol. 82, Iss. 13, pp. 2485-2498
Open Access | Times Cited: 21
Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice
Bhairavi Tolani, Anna Celli, Yanmin Yao, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 12, pp. 1834-1844
Open Access | Times Cited: 21
From bench to bedside: current development and emerging trend of KRAS-targeted therapy
Yi Chen, Qiu-pei Liu, Hua Xie, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 4, pp. 686-703
Closed Access | Times Cited: 11
Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders
Anaïs Cornebois, Marie Sorbara, Margot Cristol, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109802-109802
Open Access | Times Cited: 4
The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors
Kotaro Sakamoto, Bangzhong Lin, Kazuto Nunomura, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Biologics-based degraders — an expanding toolkit for targeted-protein degradation
Derek VanDyke, Jonathan D. Taylor, Kyle J. Kaeo, et al.
Current Opinion in Biotechnology (2022) Vol. 78, pp. 102807-102807
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top